首页> 外国专利> METHOD OF PREDICTING LUNG CANCER ARISING IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE

METHOD OF PREDICTING LUNG CANCER ARISING IN PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG DISEASE

机译:预测慢性阻塞性肺疾病患者肺癌的预测方法

摘要

FIELD: medicine.;SUBSTANCE: in blood of patients with chronic obstructive lung disease defined are content of CD3+ CD16-, IgE, spontaneous proliferation of T-lymphocytes (activated cells), percent of lymphocytes with increased quantity of DNA (G1-phase), phagocytic index, stimulated by zymosan test with nitro-blue tetrazolium (NBT- induced) is carried out. If values of CD3+ CD16- content are over 1.85·103, IgE over 330 IU/ml, of spontaneous proliferation less than 20%, percent of lymphocytes with increased DNA (G1-phase) quantity less than 1.9 phagocytic index over 52, stimulated by zymosan test with nitro-blue tetrazolium over 38% lung cancer development is predicted.;EFFECT: application of claimed method allows to predict development of disease accurately.;2 ex
机译:领域:医学;研究对象:慢性阻塞性肺疾病患者血液中的CD3 + CD16-,IgE含量,T淋巴细胞(活化细胞)的自发增殖,DNA量增加的淋巴细胞百分比(G1期)进行了由酵母蓝试验(用硝基蓝四唑(NBT诱导)通过酵母聚糖试验刺激)的吞噬指数。如果CD3 + CD16-含量的值超过1.85·10 3 ,则IgE超过330 IU / ml,自发增殖低于20%,DNA(G1期)数量增加的淋巴细胞百分比低于预计1.9的吞噬指数超过52,由酵母蓝试验和硝基蓝四唑鎓刺激超过38%的肺癌发生。效果:使用要求保护的方法可以准确预测疾病的发生。2

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号